# Atrial Fibrillation (AF)

## Types

1. **Paroxysmal AF**
   - Episodes last < 7 days (often < 48 hours) and terminate spontaneously or with intervention.
1. **Persistent AF**
   - Lasts > 7 days and requires intervention (e.g., cardioversion) to restore sinus rhythm.
1. **Long-standing Persistent AF**
   - Lasts > 12 months without successful termination.
1. **Permanent AF**
   - Sinus rhythm is no longer pursued; AF is accepted as the ongoing rhythm.
1. **Non-valvular AF**
   - AF without moderate-to-severe mitral stenosis or a mechanical heart valve.

## Management

### Emergency Management

1. Airway
   - Ensure airway patency and oxygenation if needed.
1. Breathing
   - Oxygen supplementation if hypoxic.
   - Non-invasive ventilation if respiratory distress.
1. Circulation
   - **If hemodynamically unstable** (e.g., SBP < 90 mmHg, pulmonary edema, ischemia) → **Immediate synchronized electrical cardioversion** (start with 100-200J biphasic).
   - **If stable but tachycardic (>150 bpm)** → IV rate control with:
     - `Beta-blockers` (e.g., `metoprolol` IV): first-line.
     - `CCBs` (e.g., `diltiazem`, `verapamil` IV): if no heart failure.
     - `Amiodarone IV`: if AF with heart failure.
   - **If rapid AF due to pre-excitation (WPW syndrome)** → Avoid beta-blockers, CCBs, and digoxin; use `procainamide` or immediate cardioversion.
1. Disability
   - Assess neurological status (risk of stroke).
1. Exposure
   - Look for underlying causes (e.g., sepsis, MI, thyrotoxicosis).
1. Fluids & Further Investigations
   - **Investigations:** ECG, electrolytes, cardiac markers, TSH, echocardiography.
   - **Anticoagulation**: If AF duration **>48 hours**, do **not cardiovert** unless anticoagulated for **≥3 weeks** or after TEE ruling out thrombus.

### Long-Term Management

#### General

- Lifestyle modifications (e.g., weight loss, smoking cessation, exercise).
- Treat underlying causes (hypertension, hyperthyroidism, sleep apnea).
- Avoid triggers (alcohol, caffeine, excessive stress).

#### Rate Control

> First line for Permanent & Persistent AF.

- Beta-blockers (e.g., `metoprolol`, `bisoprolol`) (In heart failure or post-MI patients)
- Non-dihydropyridine CCBs (e.g., `diltiazem`, `verapamil`) (Avoid in heart failure with reduced ejection fraction (HFrEF))
- `Digoxin`

#### Rhythm Control

> Preferred in young, symptomatic, paroxysmal AF or if heart failure due to AF or Persistent AF

1. **Cardioversion**:
   - **Electrical** if unstable.
   - **Pharmacological**:
     - `Class Ic antiarrhythmics` (e.g., `flecainide`, `propafenone`)(~~Avoid in structural heart disease~~)
     - `Class III antiarrhythmics` (e.g., `amiodarone`, `dronedarone`, `sotalol`) (`amiodarone` preferred in HF)
1. **Catheter Ablation**:
   - First-line for symptomatic **paroxysmal AF**, especially in younger patients.

#### Anti-coagulants

> CHA₂DS₂-VASc stroke risk scoring system for non-valvular atrial fibrillation

| Risk Factor                  | Points |
| ---------------------------- | ------ |
| `C`ongestive heart failure   | 1      |
| `H`ypertension               | 1      |
| `A`ge ≥75 years              | 2      |
| `D`iabetes mellitus          | 1      |
| `S`troke/TIA/Thromboembolism | 2      |
| `V`ascular disease (MI, PAD) | 1      |
| `A`ge 65-74 years            | 1      |
| `S`ex `c`ategory (Female)    | 1      |

- **Score ≥2** (men) or **≥3** (women) → `Anticoagulation` required.
- **Preferred:** `DOACs` (`apixaban`, `rivaroxaban`, `dabigatran`).
- **If mechanical valve/mitral stenosis:** `Warfarin` (target INR 2-3).

<details>
<summary>HAS-BLED bleeding risk scoring system for patients receiving oral anticoagulantion</summary>

| Risk Factor                     | Points |
| ------------------------------- | ------ |
| `H`ypertension                  | 1      |
| `A`bnormal renal/liver function | 1 or 2 |
| `S`troke history                | 1      |
| `B`leeding history              | 1      |
| `L`abile INR (if on warfarin)   | 1      |
| `E`lderly (≥ 65 years)          | 1      |
| `D`rugs/alcohol use             | 1 or 2 |

- **Score ≥3** → High bleeding risk, consider alternatives or monitor closely.

</details>
